Skip to main content

Eisner Mark

In the past year, 2 open-market sale filings worth $49.5K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$49.5K
2 filings
Net
−$49.5K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Eisner Mark as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

VIR Vir Biotechnology, Inc.

EVP and Chief Medical Officer3 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 26, 2026 (view filing)Feb 24-252 daysEisner MarkEVP and Chief Medical OfficerSSale−3.50K$9.69−$34.0K−2.2%154.0K after2 lots10b5-1
Feb 24, 2026 (view filing)Feb 231 dayEisner MarkEVP and Chief Medical OfficerSSale−2.09K$7.45−$15.6K−1.3%157.5K after10b5-1
Jul 17, 2025 (view filing)Jul 15-172 daysEisner MarkEVP and Chief Medical OfficerSSale−10.4K$5.47−$56.8K−9.0%104.6K after2 lots10b5-1

KYNB Kyntra Bio, Inc.

EVP, Chief Medical Officer5 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 9, 2023 (view filing)Jun 72 daysEisner MarkEVP, Chief Medical OfficerSSale−2.04K$17.04−$34.8K−1.2%162.9K after
Jun 5, 2023 (view filing)Jun 23 daysEisner MarkEVP, Chief Medical OfficerSSale−1.09K$18.83−$20.5K−0.7%164.9K after
Apr 6, 2023 (view filing)Apr 42 daysEisner MarkChief Medical OfficerSSale−9.18K$18.78−$172.4K−5.2%166.0K after
Mar 10, 2023 (view filing)Mar 8-102 daysEisner MarkChief Medical OfficerSSale−17.5K$20.60−$360.6K−9.1%175.2K after3 lots
Mar 6, 2023 (view filing)Mar 24 daysEisner MarkChief Medical OfficerSSale−1.19K$21.87−$26.0K−0.7%172.5K after